These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20349754)

  • 41. Benefit of amoxicillin in differentiating between TB suspects whose initial AFB sputum smears are negative.
    Kudjawu Y; Massari V; Sow O; Bah B; Larouzé B; Murray JF
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):441-6. PubMed ID: 16602410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased yield of smear positive pulmonary TB cases by screening patients with > or =2 weeks cough, compared to > or =3 weeks and adequacy of 2 sputum smear examinations for diagnosis.
    Thomas A; Chandrasekaran V; Joseph P; Rao VB; Patil AB; Jain DK; Chowdhary D; Saibabu ; Mahapatra S; Devi S; Wares F; Narayanan PR
    Indian J Tuberc; 2008 Apr; 55(2):77-83. PubMed ID: 18516823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-course tuberculosis chemotherapy in rural Somalia.
    Agutu WO
    East Afr Med J; 1997 Jun; 74(6):348-52. PubMed ID: 9487394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of health-related quality of life in patients with pulmonary tuberculosis under programme conditions.
    Aggarwal AN; Gupta D; Janmeja AK; Jindal SK
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):947-53. PubMed ID: 23743314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy.
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):40-5. PubMed ID: 11263515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region.
    van den Boogaard J; Lyimo R; Irongo CF; Boeree MJ; Schaalma H; Aarnoutse RE; Kibiki GS
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1524-9. PubMed ID: 19919771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Compliance in pulmonary tuberculosis patients using directly observed treatment short course.
    Dosumu EA
    Afr J Med Med Sci; 2001; 30(1-2):111-4. PubMed ID: 14510163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi].
    Masuyama H; Takase A; Aoki M; Shimao T
    Kekkaku; 1998 Dec; 73(12):697-703. PubMed ID: 10028803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of care for elderly pulmonary tuberculosis patients].
    Sasaki Y; Yamagishi F; Yagi T; Hashimoto T; Bekku R; Kawasaki T; Shinozaki A
    Kekkaku; 2007 Oct; 82(10):733-9. PubMed ID: 18018597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment seeking behaviour of smear-positive tuberculosis patients diagnosed in Burkina Faso.
    Ouédraogo M; Kouanda S; Boncoungou K; Dembélé M; Zoubga ZA; Ouédraogo SM; Coulibaly G
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):184-7. PubMed ID: 16499258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DOTS strategy and community participation: an experience in the Ecuadorian Andes.
    Romero-Sandoval N; Flores-Carrera O; Molina MA; Jácome M; Navarro A; Martin M
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1569-71. PubMed ID: 19919780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa.
    Winqvist N; Nauclér A; Gomes V; Djamanca I; Koivula T; Jensen H; Dias F; Biberfeld G; Källenius G; Norberg R
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):845-52. PubMed ID: 10985653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morbidity and mortality at five years after initiating Category I treatment among patients with new sputum smear positive pulmonary tuberculosis.
    Lisha PV; James PT; Ravindran C
    Indian J Tuberc; 2012 Apr; 59(2):83-91. PubMed ID: 22838205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does health-related quality of life among adults with pulmonary tuberculosis improve across the treatment period? A hospital-based cross sectional study in Mbale Region, Eastern Uganda.
    Kisaka SM; Rutebemberwa E; Kasasa S; Ocen F; Nankya-Mutyoba J
    BMC Res Notes; 2016 Oct; 9(1):467. PubMed ID: 27756438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis.
    Pasipanodya JG; Miller TL; Vecino M; Munguia G; Bae S; Drewyer G; Weis SE
    Chest; 2007 Nov; 132(5):1591-8. PubMed ID: 17890471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health-Related Quality of Life (HRQoL) scores vary with treatment and may identify potential defaulters during treatment of tuberculosis.
    Olufemi AO; Chikaodinaka AA; Abimbola P; Oluwatoyin AT; Oluwafunmilola A; Fasanmi KT; Efosa EG
    Malawi Med J; 2018 Dec; 30(4):283-290. PubMed ID: 31798808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol.
    Rachow A; Ivanova O; Wallis R; Charalambous S; Jani I; Bhatt N; Kampmann B; Sutherland J; Ntinginya NE; Evans D; Lönnroth K; Niemann S; Schaible UE; Geldmacher C; Sanne I; Hoelscher M; Churchyard G
    BMC Pulm Med; 2019 Jan; 19(1):4. PubMed ID: 30616617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary tuberculosis: the day after.
    Akkara SA; Shah AD; Adalja M; Akkara AG; Rathi A; Shah DN
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):810-3. PubMed ID: 23676167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena.
    Ralph AP; Kenangalem E; Waramori G; Pontororing GJ; Sandjaja ; Tjitra E; Maguire GP; Kelly PM; Anstey NM
    PLoS One; 2013; 8(11):e80302. PubMed ID: 24312209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis.
    Suzuki T; Shirai T; Hirai K; Tanaka Y; Watanabe H; Endo Y; Shimoda Y; Saigusa M; Akamatsu T; Yamamoto A; Morita S; Asada K
    Respir Investig; 2019 May; 57(3):252-259. PubMed ID: 30738923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.